RELATIONSHIP BETWEEN GLYCOCALYX COMPONENTS AND MICROALBUMINURIA IN PATIENTS WITH DIABETES MELLITUS

Authors

  • Shanza Rafi
  • Kamran Shauket
  • Shazia Naz
  • Zunairah Hamayun
  • Nasir Islam
  • Tayyaba Yasin
  • Hafsa Yasin
  • Filza Karim
  • Rizwana Dilshad

DOI:

https://doi.org/10.53555/f3es7q76

Keywords:

Diabetes; Microalbuminuria; Glycocalyx metabolites.

Abstract

Diabetes mellitus is a disease of deregulated blood glucose homeostasis. Microalbuminuria has been
described as an early sign of kidney damage. The aim of the study was to determine the association
of glycocalyx metabolites with microalbuminuria in type 1 diabetic patients. To determine the
association of glycocalyx metabolites with microalbuminuria in diabetic patients. This cross-sectional
study was recruited from the 90 patient’s department of Children's Hospital on the recommendation
of a consultant endocrinologist. Patients were designated as having microalbuminuria if they had a
24-h urine measurement >30 mg or an albumin-to-creatinine ratio >30 mg/g albumin-to-creatinine.
Total cholesterol, HDL cholesterol, and triglycerides were measured by standard enzymatic methods.
Blood and urine samples were obtained from diabetic patients. A probability value of P<0.05 was
determined to be statistically significant. The analysis of patient ages indicated a mean age of
12.62±1.73 years. Out of the total of 90 patients, 55 (61.11%) were identified as male, while 35
(38.89%) were identified as female. The Mean albumin to creatinine ration in patients was
356.17±139.24 respectively. The Mean cholesterol level in patients was 182.43±50.89. The meantriglyceride level in patients was 154.17±118.49. Mean HbA1c level in patients was 11.52±1.36.
Mean hyaluronic acid level in patients was 283.83±29.51. Hyaluronic acid displayed weak positive
correlations with creatinine (r=0.348) and HbA1c levels (r=0.209), and a moderate correlation with
the albumin-to-creatinine ratio (r=0.424). A positive significant correlation was observed between
hyaluronic acid and ACR. This study suggests that there is a correlation between hyaluronan and ACR
in children with T1DM, indicating the importance of monitoring these measures in the management
of T1DM.

Author Biographies

  • Shanza Rafi

    Demonstrator at Department of Physiology, Multan Medical and Dental College, Multan,
    Pakistan. 

  • Kamran Shauket

    Senior Registrar at Sahiwal Teaching Hospital, Sahiwal, Pakistan. 

  • Shazia Naz

    Demonstrator in Department of Biochemistry at Sahiwal Medical College, Sahiwal, Pakistan.

  • Zunairah Hamayun

    Associate Professor in Department of Physiology at Multan Medical and Dental college,
    Multan, Pakistan. 

  • Nasir Islam

    Assistant Professor in Department of Biochemistry at Multan Medical and Dental College, Multan,
    Pakistan. 

  • Tayyaba Yasin

    Molecular Biology and Biotechnology at The University of Lahore, Lahore, Pakistan. 

  • Hafsa Yasin

    Doctor of Physical Therapy at The University of Lahore, Pakistan. 

  • Filza Karim

    Senior Demonstrator at Department of Physiology, Sheikh Zayed Medical College, Pakistan. 

  • Rizwana Dilshad

    Associate professor at Swedish College of Pharmacy and Allied Health Sciences, Rahim Yar
    Khan, Pakistan. 

References

1. Ahn, M. B., Cho, K. S., Kim, S. K., Kim, S. H., Cho, W. K., Jung, M. H., Suh, J.-S., and Suh, B.-

K. (2021). Poor Glycemic Control Can Increase the Plasma Kidney Injury Molecule-1

Concentration in Normoalbuminuric Children and Adolescents with Diabetes Mellitus. Children,

8(5), 417.

2. Aldecoa, C., Llau, J. V., Nuvials, X., and Artigas, A. (2020). Role of albumin in the preservation

of endothelial glycocalyx integrity and the microcirculation: a review. Annals of intensive care,

10, 1-12.

3. Alphonsus, C., and Rodseth, R. (2014). The endothelial glycocalyx: a review of the vascular

barrier. Anaesthesia, 69(7), 777-784.

4. Balbotkina, E., and Kutina, A. (2023). Structure and Properties of the Glomerular Filtration

Barrier in Vertebrates: Role of a Charge in Protein Filtration. Journal of Evolutionary

Biochemistry and Physiology, 59(6), 1891-1910.

5. Butler, M. (2018). Aldosterone-induced Endothelial Glycocalyx Dysfunction, a Potential

Therapeutic Target in Proteinuria? University of Bristol].

6. Cortinovis, M., Perico, N., Ruggenenti, P., Remuzzi, A., and Remuzzi, G. (2022). Glomerular

hyperfiltration. Nature reviews nephrology, 18(7), 435-451.

7. Dogné, S., and Flamion, B. (2020). Endothelial glycocalyx impairment in disease: focus on

hyaluronan shedding. The American journal of pathology, 190(4), 768-780.

8. Dong, Q., Huang, J., Liu, S., Yang, L., Li, J., Li, B., Zhao, X., Li, Z., and Wu, L. (2019). A survey

on glycemic control rate of type 2 diabetes mellitus with different therapies and patients’

satisfaction in China. Patient preference and adherence, 1303-1310.

9. Fayfman, M., and Haw, S. (2017). Diabetes in racial and ethnic minorities in the United States:

Individualizing approaches to diagnosis and management. Current Diabetes Reviews, 13(3), 239-

250.

10. Franceković, P., and Gliemann, L. (2023). Endothelial Glycocalyx Preservation—Impact of

Nutrition and Lifestyle. Nutrients, 15(11), 2573.

11. Herman, W. H., Schillinger, D., Bolen, S., Boltri, J. M., Bullock, A., Chong, W., Conlin, P. R.,

Cook IV, J. W., Dokun, A., and Fukagawa, N. (2023). The National Clinical Care Commission

report to Congress: recommendations to better leverage federal policies and programs to prevent

and control diabetes. Diabetes care, 46(2), 255-261.

12. Hu, Z., Cano, I., and D’Amore, P. A. (2021). Update on the role of the endothelial glycocalyx in

angiogenesis and vascular inflammation. Frontiers in Cell and Developmental Biology, 9,

734276.

13. Hull, R. L., Bogdani, M., Nagy, N., Johnson, P. Y., and Wight, T. N. (2015). Hyaluronan: a

mediator of islet dysfunction and destruction in diabetes? Journal of Histochemistry and

Cytochemistry, 63(8), 592-603.

14. Kazemzadeh, K., Bayani, M., Khademi, R., Sadat-Madani, S.-F., Habibzadeh, A., Shirani, M.,

Ghadri, H., Abbasalizadeh, M., Izadi, E., and Rezaee, M. (2024). Association of serum omentin

levels with microvascular complications of type 2 diabetes mellitus: a systematic review and

meta-analysis. Journal of Diabetes and Metabolic Disorders, 23(1), 239-249.

15. Korakas, E., Ikonomidis, I., Markakis, K., Raptis, A., Dimitriadis, G., and Lambadiari, V. (2020).

The endothelial glycocalyx as a key mediator of albumin handling and the development of

diabetic nephropathy. Current Vascular Pharmacology, 18(6), 619-631.

16. Ledeganck, K. J., den Brinker, M., Peeters, E., Verschueren, A., De Winter, B. Y., France, A.,

Dotremont, H., and Trouet, D. (2021). The next generation: Urinary epidermal growth factor is

associated with an early decline in kidney function in children and adolescents with type 1

diabetes mellitus. diabetes research and clinical practice, 178, 108945.

17. Marcovecchio, M. L., Colombo, M., Dalton, R. N., McKeigue, P. M., Benitez‐Aguirre, P.,

Cameron, F. J., Chiesa, S. T., Couper, J. J., Craig, M. E., and Daneman, D. (2020). Biomarkers

associated with early stages of kidney disease in adolescents with type 1 diabetes. Pediatric

diabetes, 21(7), 1322-1332.

18. Masola, V., Zaza, G., Arduini, A., Onisto, M., and Gambaro, G. (2021). Endothelial glycocalyx

as a regulator of fibrotic processes. International journal of molecular sciences, 22(6), 2996.

19. Nadhiya, J., Vijayalakshmi, M., and Showbharnikhaa, S. (2024). A Brief Review on Diabetes

Mellitus. Journal of Pharma Insights and Research, 2(1), 117-121.

20. Nasri, H., and Rafieian-Kopaei, M. (2015). Diabetes mellitus and renal failure: Prevention and

management. Journal of research in medical sciences, 20(11), 1112-1120.

21. Popoviciu, M. S., Paduraru, L., Nutas, R. M., Ujoc, A. M., Yahya, G., Metwally, K., and Cavalu,

S. (2023). Diabetes mellitus secondary to endocrine diseases: an update of diagnostic and

treatment particularities. International journal of molecular sciences, 24(16), 12676.

22. Poredos, P., Poredos, A. V., and Gregoric, I. (2021). Endothelial dysfunction and its clinical

implications. Angiology, 72(7), 604-615.

23. Premaratne, E., Verma, S., Ekinci, E. I., Theverkalam, G., Jerums, G., and MacIsaac, R. J. (2015).

The impact of hyperfiltration on the diabetic kidney. Diabetes and metabolism, 41(1), 5-17.

24. Qi, B., Lou, Y., Zhu, Y., Chen, Y., Yang, S., Meng, F., Pan, Z., Liu, S., Yan, G., and Lu, X.

(2024). Elevated RHAMM as a biomarker for predicting diabetic kidney disease in patients with

type 2 diabetes. Clinical Kidney Journal, 17(7).

25. Rabelink, T. J., and De Zeeuw, D. (2015). The glycocalyx—linking albuminuria with renal and

cardiovascular disease. Nature reviews nephrology, 11(11), 667-676.

26. Rathsman, B., Haas, J., Persson, M., Ludvigsson, J., Svensson, A. M., Lind, M., Andersson

Franko, M., and Nyström, T. (2021). LDL cholesterol level as a risk factor for retinopathy and

nephropathy in children and adults with type 1 diabetes mellitus: a nationwide cohort study.

Journal of internal medicine, 289(6), 873-886.

27. Salmon, A. H., and Satchell, S. C. (2012). Endothelial glycocalyx dysfunction in disease:

albuminuria and increased microvascular permeability. The Journal of pathology, 226(4), 562-

574.

28. Sana, M. A., Chaudhry, M., Malik, A., Iqbal, N., Zakiuddin, A., and Abdullah, M. (2020).

Prevalence of microalbuminuria in type 2 diabetes mellitus. Cureus, 12(12).

29. Scilletta, S., Di Marco, M., Miano, N., Filippello, A., Di Mauro, S., Scamporrino, A., Musmeci,

M., Coppolino, G., Di Giacomo Barbagallo, F., and Bosco, G. (2023). Update on diabetic kidney

disease (DKD): focus on non-albuminuric DKD and cardiovascular risk. Biomolecules, 13(5),

752.

30. Selby, N. M., and Taal, M. W. (2020). An updated overview of diabetic nephropathy: Diagnosis,

prognosis, treatment goals and latest guidelines. Diabetes, Obesity and Metabolism, 22, 3-15.

31. Sharma, M., Singh, V., Sharma, R., Koul, A., McCarthy, E. T., Savin, V. J., Joshi, T., and

Srivastava, T. (2022). Glomerular biomechanical stress and lipid mediators during cellular

changes leading to chronic kidney disease. Biomedicines, 10(2), 407.

32. Wu, G., Liu, S., Hagenstein, J., Alawi, M., Hengel, F. E., Schaper, M., Akyüz, N., Liao, Z.,

Wanner, N., and Tomas, N. M. (2024). Adeno-associated virus–based gene therapy treats

inflammatory kidney disease in mice. The Journal of Clinical Investigation, 134(17).

33. Yu, H., Song, Y.-Y., and Li, X.-H. (2023). Early diabetic kidney disease: focus on the glycocalyx.

World journal of diabetes, 14(5), 460.

Downloads

Published

2024-09-25

How to Cite

Shanza Rafi, Kamran Shauket, Shazia Naz, Zunairah Hamayun, Nasir Islam, Tayyaba Yasin, Hafsa Yasin, Filza Karim, & Rizwana Dilshad. (2024). RELATIONSHIP BETWEEN GLYCOCALYX COMPONENTS AND MICROALBUMINURIA IN PATIENTS WITH DIABETES MELLITUS. Journal of Population Therapeutics and Clinical Pharmacology, 31(9), 1106-1114. https://doi.org/10.53555/f3es7q76
More Citation Formats

Issue

Section

Articles

How to Cite

Shanza Rafi, Kamran Shauket, Shazia Naz, Zunairah Hamayun, Nasir Islam, Tayyaba Yasin, Hafsa Yasin, Filza Karim, & Rizwana Dilshad. (2024). RELATIONSHIP BETWEEN GLYCOCALYX COMPONENTS AND MICROALBUMINURIA IN PATIENTS WITH DIABETES MELLITUS. Journal of Population Therapeutics and Clinical Pharmacology, 31(9), 1106-1114. https://doi.org/10.53555/f3es7q76

Most read articles by the same author(s)

1 2 > >>